These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4844399)

  • 1. Proceedings: Dihydrotachysterol in the treatment of bone abnormality in patients with renal failure undergoing chronic hemodialysis.
    Suda A; Ota K; Shirasu H
    Calcif Tissue Res; 1974; 15(2):159-60. PubMed ID: 4844399
    [No Abstract]   [Full Text] [Related]  

  • 2. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF; Borra S; Sagar S
    Trans Assoc Am Physicians; 1970; 83():245-53. PubMed ID: 5505392
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrotachysterol and calcitriol in long-term dialyzed patients with renal bone disease.
    Wilczek H; Stĕpán J; Pacovský V
    Acta Univ Carol Med (Praha); 1986; 32(5-6):339-43. PubMed ID: 3439519
    [No Abstract]   [Full Text] [Related]  

  • 4. Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.
    Kliger AS; Yap P; Jensen P; Finkelstein FO
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():184-90. PubMed ID: 1029884
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 6. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic uremia in childhood. II. Hemodialysis.
    Potter D; Larsen D; Leumann E; Perin D; Simmons J; Piel CF; Holliday MA
    Pediatrics; 1970 Nov; 46(5):678-89. PubMed ID: 4921218
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial Brazilian experience with short-duration in-center daily hemodialysis.
    Lugon JR; Andre MB
    Hemodial Int; 2005 Jan; 9(1):3-6. PubMed ID: 16191048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and therapy of regulatory hyperparathyroidism in kidney patients].
    Koall W; Mampel E; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Apr; 37(7):197-201. PubMed ID: 7048771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ocular changes in patients with terminal chronic uremia under treatment with periodic hemodialysis].
    Tittarelli R; Palmerini S; Mioli V; Figus S
    Minerva Med; 1979 Apr; 70(20):1425-9. PubMed ID: 450278
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperkaliemic complication in patients undergoing periodical hemodialysis].
    Perna N; De Pascale C; Cirillo D; Giordano C
    Minerva Nefrol; 1970; 17(3):83-4. PubMed ID: 5515030
    [No Abstract]   [Full Text] [Related]  

  • 13. [Osteodystrophies of chronic uremia].
    Meyrier A; Verger D; Richet G
    Schweiz Rundsch Med Prax; 1971 Dec; 60(50):1667-70. PubMed ID: 5140324
    [No Abstract]   [Full Text] [Related]  

  • 14. [The heart of patients with chronic renal failure on periodic hemodialysis: echocardiographic aspects. Apropos of 24 cases].
    Revillon L; Scholl JM; Almange C; Chevet D; Hervé JP
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):969-77. PubMed ID: 6456710
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone and soft tissue damage in patients with chronic renal failure during treatment by systematic hemodialysis].
    Nenov D; Kolev Z; Vicheva S
    Urol Nefrol (Mosk); 1984; (6):53-6. PubMed ID: 6516077
    [No Abstract]   [Full Text] [Related]  

  • 17. Azotemic renal osteodystrophy.
    Baker J; Anderson KC; Ross G
    Mo Med; 1966 Oct; 63(10):807-10. PubMed ID: 5976677
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperprebetalipoproteinemia in patients treated by hemodialysis: clinico-experimental study].
    Notarbartolo A; Stalteri A; Averna MR; Picone G; Piovana U; Montalto G; Battianati E; De Simone M
    G Clin Med; 1980 May; 61(5):386-401. PubMed ID: 7450358
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 May; 143(5):960-3. PubMed ID: 6089682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.